The role AI can play in drug discovery and development is well documented, but the recent global pandemic has highlighted the growing importance this technology has in the fight against disease, writes Lu Rahman.
EPM speaks to Rami Cassis, executive chairman of pharmaceutical serialisation company Advanco and CEO of Parabellum Investments about the rise in counterfeit medicines during the Covid-19 pandemic.
Maurits Lugard, Dr. Dorothee Schramm, and Anna-Shari Melin from law firm Sidley & Austin explain how pharmaceutical companies with products on the EU market can address product shortages and supply chain issues in the current Covid-19 crisis.
With countries around the world beginning to consider steps to ease their lockdown restrictions now may be the best time to look at the lessons we should have learned from the Covid-19 crisis.
The generics industry is a crucial partner in the fight against Covid-19 where cross-industry partnerships and alliances are creating a new normal, writes Tony Cordrey, VP Operations, Accord Healthcare EMENA.
EPM speaks to Neil Tween, CFO at Owlstone Medical, who tells us why diagnostics still have a vital role to play in healthcare and the lessons he's learned from working in the industry.
Web content editor Ian Bolland sits down with Roger Scarlett-Smith, executive vice president at Thornton & Ross in Huddersfield to find out how the company operates.
Contract development and manufacturing organisation (CDMO) Cobra Biologics and the Karolinska Institutet (KI) have been awarded €3 million in emergency funding to take a DNA vaccine for Covid-19 through phase I clinical trial testing.
